Angela Damato Loredana De Marco Silvia Serra Mario Larocca Alicia Garcia Arias Ermanno Rondini Carmine Pinto
10.3389/fonc.2021.670415
Front Oncol
2021 Jun 17;11:670415.
colitis immune checkpoint inhibitors non-small-cell lung cancer pembrolizimab survival
CC BY
https://pubmed.ncbi.nlm.nih.gov/34221986/
Case Reports
PMC8248363
34221986
Persistent Response and Prolonged Survival Following Pembrolizumab Discontinuation Due to Long-Lasting Autoimmune Colitis in Advanced NSCLC: A Case Report
2021